Dr. Megan Kruse & Dr. Lukas Delasos - ADC Integration & Toxicity in Breast and Thoracic Oncology episode artwork

EPISODE · May 15, 2026 · 1H

Dr. Megan Kruse & Dr. Lukas Delasos - ADC Integration & Toxicity in Breast and Thoracic Oncology

from Community Health Media · host Community Health Media

As the ADC landscape expands, how is datopotamab deruxtecan redefining the treatment paradigm for both breast and lung cancer?In this episode of CHM Conversations, Dr. Megan Kruse and Dr. Lukas Delasos break down the clinical integration of next-generation ADCs. The discussion differentiates the roles of ADCs such as datopotamab deruxtecan and trastuzumab deruxtecan, examining their impact across HER2-directed and Trop-2 targeted settings in both metastatic breast cancer and thoracic oncology.Beyond the data, the clinicians share practical insights on navigating sequencing challenges, resistance mechanisms, and the evolving role of biomarkers in personalizing care. A major focus is placed on proactive toxicity management, highlighting essential protocols to ensure treatment continuity and optimize patient outcomes.A strategic resource for oncology clinicians navigating the future of ADC therapy, biomarker-guided treatment selection, and precision oncology across breast and lung cancer.🎧 Watch more expert-led oncology conversations from CHM Conversations.#BreastCancer #LungCancer #NSCLC #ADC #AntibodyDrugConjugates #HER2Low #EGFR #DatopotamabDeruxtecan #TrastuzumabDeruxtecan #PrecisionOncology #TargetedTherapy #MedicalOncology #ThoracicOncology #BreastOncology #ILD #CommunityHealthMedia–Thanks for watching!Our podcasts are also available on: • Spotify - https://spotf.fi/chm-podcast • Amazon Music - https://amazn.so/chm-podcast • Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248 • Castbox - https://castbox.fm/vh/6735434 • Goodpods - https://goodpods.com/profile/chm-111066 • iHeartRadio - https://iheart.com/podcast/291542082 • Pocket Casts - https://pca.st/3ncdh11o–Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.We specialize in: • Peer to peer interviews, panels & round-tables • Curated live events & conferences • Professional in-depth content & research updates • Interactive learning modules & webinars • Live & on-demand webcasts & podcastsLearn more about us here - https://communityhealth.media

Episode metadata supplied by the publisher feed · Published May 15, 2026

Embed this episode

Ready to play

Dr. Megan Kruse & Dr. Lukas Delasos - ADC Integration & Toxicity in Breast and Thoracic Oncology

0:00 1:00:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Community Health Media?

This episode is 1 hour and 0 minutes long.

When was this Community Health Media episode published?

This episode was published on May 15, 2026.

Can I download this Community Health Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!